These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 34186296)

  • 1. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
    Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
    Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional high iron deposition on quantitative susceptibility mapping correlates with cognitive decline in type 2 diabetes mellitus.
    Hu R; Gao B; Tian S; Liu Y; Jiang Y; Li W; Li Y; Song Q; Wang W; Miao Y
    Front Neurosci; 2023; 17():1061156. PubMed ID: 36793541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
    Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
    Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
    Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
    J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of deep grey nuclei susceptibility in early childhood: a quantitative susceptibility mapping and R2* study at 3 Tesla.
    Raab P; Ropele S; Bültmann E; Salcher R; Lanfermann H; Wattjes MP
    Neuroradiology; 2022 May; 64(5):1021-1031. PubMed ID: 34787698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2
    Cheng Q; Huang J; Liang J; Ma M; Zhao Q; Lei X; Shi C; Luo L
    Exp Ther Med; 2020 Jun; 19(6):3778-3786. PubMed ID: 32346442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.
    Cobzas D; Sun H; Walsh AJ; Lebel RM; Blevins G; Wilman AH
    J Magn Reson Imaging; 2015 Dec; 42(6):1601-10. PubMed ID: 25980643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep grey matter iron accumulation in alcohol use disorder.
    Juhás M; Sun H; Brown MRG; MacKay MB; Mann KF; Sommer WH; Wilman AH; Dursun SM; Greenshaw AJ
    Neuroimage; 2017 Mar; 148():115-122. PubMed ID: 28065850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.
    Bilgic B; Pfefferbaum A; Rohlfing T; Sullivan EV; Adalsteinsson E
    Neuroimage; 2012 Feb; 59(3):2625-35. PubMed ID: 21925274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative MRI susceptibility mapping reveals cortical signatures of changes in iron, calcium and zinc in malformations of cortical development in children with drug-resistant epilepsy.
    Lorio S; Sedlacik J; So PW; Parkes HG; Gunny R; Löbel U; Li YF; Ogunbiyi O; Mistry T; Dixon E; Adler S; Cross JH; Baldeweg T; Jacques TS; Shmueli K; Carmichael DW
    Neuroimage; 2021 Sep; 238():118102. PubMed ID: 34058334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
    Meng H; Zhang D; Sun Q
    Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility.
    Li X; Chen L; Kutten K; Ceritoglu C; Li Y; Kang N; Hsu JT; Qiao Y; Wei H; Liu C; Miller MI; Mori S; Yousem DM; van Zijl PCM; Faria AV
    Neuroimage; 2019 May; 191():337-349. PubMed ID: 30738207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
    Casanova F; Tian Q; Williamson DS; Qian Y; Zweibaum D; Ding J; Atkins JL; Melzer D; Ferrucci L; Pilling LC
    Neurobiol Dis; 2024 Jul; 197():106539. PubMed ID: 38789058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
    Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
    J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
    Betts MJ; Acosta-Cabronero J; Cardenas-Blanco A; Nestor PJ; Düzel E
    Neuroimage; 2016 Sep; 138():43-63. PubMed ID: 27181761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
    Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
    Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
    Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
    Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying Brain Iron in Hereditary Hemochromatosis Using R2* and Susceptibility Mapping.
    Sethi SK; Sharma S; Gharabaghi S; Reese D; Chen Y; Adams P; Jog MS; Haacke EM
    AJNR Am J Neuroradiol; 2022 Jul; 43(7):991-997. PubMed ID: 35798390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.